Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
19 hedge funds and large institutions have $8.91M invested in Intellipharmaceuticals International Inc. in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
7% more capital invested
Capital invested by funds: $8.3M → $8.91M (+$612K)
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
32% less call options, than puts
Call options by funds: $207K | Put options by funds: $303K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.21M |
| 2 |
Morgan Stanley
New York
|
+$400K |
| 3 |
Jane Street
New York
|
+$153K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$152K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$77.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$188K |
| 2 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$113K |
| 3 |
Two Sigma Investments
New York
|
-$46K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9.24K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$4K |
IPCI Hedge Fund Activity: Q2 2014 in Review
19 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q2 2014, worth a combined $8.91M — up 7.4% from $8.3M a quarter earlier.
Fund positioning in IPCI was balanced in Q2 2014: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.21M. The largest seller was Credit Suisse, exiting entirely with an estimated $188K sold.
- 19 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $8.91M of Intellipharmaceuticals International Inc. stock for Q2 2014, up 7.4% quarter-over-quarter.
- 4 funds opened new Intellipharmaceuticals International Inc. positions in Q2 2014 and 4 closed out, a net change of 0 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q2 2014 was Sabby Management, an estimated $1.21M added.
- The largest Intellipharmaceuticals International Inc. seller in Q2 2014 was Credit Suisse, an estimated $188K sold.
Based on aggregated 13F filings for Q2 2014.